Hacia una vacuna contra el Coronavirus causante de la Covid-19
En el Grupo de Nanomedicina Veterinaria del IFAB (INTA EEA Bariloche/CONICET), junto a la Dirección Médica de Laboratorios Bagó S.A., estamos trabajando en el desarrollo de una vacuna génica contra SARS-CoV-2, económica, escalable y que permita la incorporación de nuevas variantes con facilidad.
Saved in:
Main Authors: | Mignaqui, Ana Clara, Ghersa, Federica, Marcellino, Romanela, Faraldo, Joaquin, Carignano, María de los Angeles, Tatsch, Veronica, De la Puente, Eduardo, Pappalardo, Juan Sebastián |
---|---|
Format: | info:ar-repo/semantics/artículo biblioteca |
Language: | spa |
Published: |
EEA Bariloche, INTA
2021-08
|
Subjects: | Vacuna, Covid-19, Coronavirinae, Nanomedicina, Vaccines, Nanomedicine, Severe Acute Respiratory Syndrome Coronavirus 2, Coronavirus del Síndrome Respiratorio Agudo Grave 2, Coronavirus, Vacuna Génica, SARS-CoV-2, |
Online Access: | http://hdl.handle.net/20.500.12123/10070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection
by: Flor, Noelia, et al.
Published: (2023-10) -
Evolution of SARS-CoV-2 during the first year of the COVID-19 pandemic in Northwestern Argentina
by: Zambrana Montaño, Romina, et al.
Published: (2022-10-06T10:36:02Z) -
Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
by: Villafañe, Luciana María, et al.
Published: (2021-12-09T13:43:44Z) -
El desafío de entender qué es el SARS-CoV-2
by: Esperbent, Cecilie Elisabet
Published: (2020-04) -
Anthropogenic infection of domestic cats with SARS-CoV-2 alpha variant B.1.1.7 lineage in Buenos Aires
by: Pecora, Andrea, et al.
Published: (2022-03)